Julie Ann Straub

Biography

Dr. Straub directs Embera’s nonclinical development and chemistry, manufacturing and controls (CMC) efforts on a consulting basis. She is an experienced pharmaceutical development consultant working with a range of development stage pharmaceutical and biotech companies from concept through FDA marketing approval for a variety of products. She is the former Executive Director of Research for Acusphere. She has over 25 years of drug development experience, which includes managing IND-enabling nonclinical programs and developing and executing CMC strategies for small pharmaceutical/biotechnology companies. Prior to establishing her consultancy, she served as Executive Director of Research for Acusphere, a specialty pharmaceutical company, including working from concept as an inventor through NDA submission for a cardiovascular imaging agent. Before holding that position she was involved in drug/biologic research and development at Alkermes, and was an NIH postdoctoral fellow at Harvard. For the past six years she has been an independent consultant advising medical product companies and academic institutions on areas of product development, CMC, nonclinical studies, regulatory affairs, project management, and specific scientific topics such as drug delivery. She received a B.S. and an M.S. in Chemistry from Caltech and a Ph.D. in Chemistry from MIT.

Research Interest

Pharmaceuticals, biotechnology,chemistry, drug development and delivery,cardiovascular imaging, biological research.